These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 15668908)

  • 1. Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities.
    Ariga T; Yu RK
    J Neurosci Res; 2005 Apr; 80(1):1-17. PubMed ID: 15668908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome: an update.
    Vucic S; Kiernan MC; Cornblath DR
    J Clin Neurosci; 2009 Jun; 16(6):733-41. PubMed ID: 19356935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiglycolipid antibody in inflammatory neuropathy].
    Kusunoki S
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1370-2. PubMed ID: 8752399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.
    Zhang G; Lopez PH; Li CY; Mehta NR; Griffin JW; Schnaar RL; Sheikh KA
    Brain; 2004 May; 127(Pt 5):1085-100. PubMed ID: 14985267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoantibodies in Guillain-Barré Syndrome].
    Uchibori A; Chiba A
    Brain Nerve; 2015 Nov; 67(11):1347-57. PubMed ID: 26560950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening for anti-glycolipid antibody profiles from patients with immune-mediated peripheral neuropathies by Dotzen Ganglio Profile Antibodies].
    Caudie C; Reymond A; Antoine JC; Petiot P; Gonnaud PM; Vial C
    Ann Biol Clin (Paris); 2006; 64(2):149-56. PubMed ID: 16556525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guillain-Barré syndrome: clinical features, immune mechanisms, and therapies].
    Nomura K
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1367-9. PubMed ID: 9128414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
    Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
    Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal proteins are target antigens in Guillain-Barré syndrome.
    Devaux JJ; Odaka M; Yuki N
    J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenetic mechanisms of autoimmune neuropathies caused by antiglycolipid antibodies].
    Kusunoki S
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1141-3. PubMed ID: 12235820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies in the Guillain-Barré syndrome.
    Kieseier BC; Hartung HP
    Semin Neurol; 2003 Jun; 23(2):159-68. PubMed ID: 12894381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
    Caudie C; Vial C; Petiot P; Bancel J; Lombard C; Gonnaud PM
    Ann Biol Clin (Paris); 2001; 59(5):567-77. PubMed ID: 11602387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features of neuropathies in a group of patients associated with anti-GalNAc-GD1a antibody].
    Tatsumoto M; Odaka M; Koga M; Hirata K; Yuki N
    Rinsho Shinkeigaku; 2004 Aug; 44(8):508-12. PubMed ID: 15471085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immune-mediated neuropathy and anti-glycolipid antibodies].
    Kaida K; Kusunoki S
    Brain Nerve; 2013 Apr; 65(4):413-23. PubMed ID: 23568989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcgamma receptors.
    van Sorge NM; van den Berg LH; Geleijns K; van Strijp JA; Jacobs BC; van Doorn PA; Wokke JH; van de Winkel JG; Leusen JH; van der Pol WL
    Ann Neurol; 2003 May; 53(5):570-9. PubMed ID: 12730990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune peripheral neuropathies.
    Bourque PR; Chardon JW; Massie R
    Clin Chim Acta; 2015 Sep; 449():37-42. PubMed ID: 25748038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
    Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
    J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
    Allen D; Giannopoulos K; Gray I; Gregson N; Makowska A; Pritchard J; Hughes RA
    J Peripher Nerv Syst; 2005 Jun; 10(2):174-80. PubMed ID: 15958128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral mechanisms in immune neuropathies.
    Koski CL
    Neurol Clin; 1992 Aug; 10(3):629-49. PubMed ID: 1501599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.